Company intelligence / Profile preview

Mead

Chicago, Illinois, United States

Ownership: Private
Employees: ~7500
Development stage: Other

Overview

Mead Johnson Nutrition is a global leader in pediatric nutrition, primarily known for its flagship Enfamil line of infant formulas. The company develops, manufactures, and markets a wide range of nutritional products for infants, children, and expectant mothers, including specialized formulas for metabolic disorders and allergies. Founded in 1905, it has established a significant presence in over 50 countries. In 2017, the company was acquired by Reckitt Benckiser, where it continues to operate as a key division within their healthcare and nutrition portfolio.

Therapeutic areas: ImmunologyMetabolic Disorders
Modalities: Nutritional formulationBiologics
Industry: Food & Nutrition

Beyond the preview

Go deeper on Mead.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mead.

Explore the full profile